Community Health selling four rural hospitals

Community Health Systems (CHS), one of the largest hospital chains in the U.S., has announced the sale of four rural hospitals as it tries to relieve some of its $15 billion debt.

The four hospitals being sold are the 95-bed Merit Health Gilmore Memorial in Amory, Mississippi; 112-bed Merit Health Batesville in Batesville, Mississippi; 181-bed Merit Health Northwest Mississippi in Clarksdale, Mississippi; and the 126-bed Highlands Regional Medical Center in Sebring, Florida.

“We are highly invested in the success of our affiliated hospitals, and we are considering how to best position them for the future,” said CHS Chairman and CEO Wayne T. Smith. “These four hospitals provide quality care and are important in each of their communities. They will benefit from alignment with a smaller organization specializing in the operation of rural hospitals. Divestiture of these assets advances our strategy to focus on a portfolio of larger hospitals and regional healthcare systems.”

The buyer is Clinton, Tennessee-based non-profit Curae Health. Curae currently operates three hospitals in Alabama, all acquired from LifePoint Health in 2015.

The terms of the deal weren’t disclosed, but CHS expects the transaction to close by the end of the year.

The company, which just two years ago was in a buying mode with its $7.6 billion purchase of Health Management Associates, had already shed 38 hospitals earlier this year by spinning them off into Quorom Health Corporation, raising around $1.2 billion. 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.